Pul Vascular Disease Flashcards
genetics of IPAH (primary pulmonary HTN)
long arm chromosome 2 2q31-32
BMPR2 gene stop codon exon mutations
AD with low penetrance
system pathologies, wegeners
systemic vasculitis > granulomatous inflammation
upper respiratory (then lower)
Kidney
symptoms Wegener’s
nasal sinus otitis
cough, hemoptysis
constitutional (joints, fever)
group I pulmonary artery htn =
precapilary
(idiopathic_
best non-invasive diagnositc for PH
echocardiogram
ANCA associated vasculitis =
wegner’s
associated with APAH
Collagen vascular disease (Scleroderma, SLE, RA)
congenital heart disease
portal HTN
HIV
Drugs
demographics wegener’s
50yo male > female
samples from ____ show more apparent hemosiderian macrophages, blood (if present)
deep in lung
antibasement membrane antibody disease =
goodpastures
poor prognosis in PH at (pressure levels)
RA pressure >10mmHg
CI < 2.2L/min2
pathways implicated in PAH pathogensis
increased endothelian
decreased NO pathway
decreased Prostacyclin pathway
group IV pul HTN =
chronic thrombotic, embolic diseases
(obstruction of proximal, distal arteries)
classic triad alveolar, capillary hemorrhage syndromes
hemoptysis
pulmonary infiltrates
enemia
Venous thromboembolism risk factors
virchows triad: stasis, injury, hypercoaguabilty
Thrombophilias (Prot C, S, ATIII, Factor V Leiden, prothrombin mutation, MTHFR, Factor VIII
**Medical risks: **hip/knee surgery, CHF, obesity, Malignancy, acquired hypercoag (CA)